Dr. Tracy, you may be right. I'm way too close to this thing, and it's not just about money. I guess it's painful to watch a dream die. I made the pick almost eight years ago, hoping, despite setbacks, the company might change the world, changing the treatment of disease.
When it hits the iceberg, I guess the realization of it forces reality to hit. I may get to my cost-basis of 1.80 with a deal, but my dream is getting snuffed out.
Never get too emotional with a stock: I'm guilty as charged. Nonetheless, when the major focus of a CEO for 1.8 months falls short, knocked down, he is often replaced.